Symbicort Turbohaler 160/4.5 Micrograms
Budesonide Micronized 180mg · Formoterol Fumarate Hydrate 5mg
Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
MFDS item code 200109101 · Approved 2001.02.06 · Insurance code 650700251,650700271
Improvement of asthma and severe chronic obstructive pulmonary disease
This medication is used for the treatment of patients with asthma and those with severe chronic obstructive pulmonary disease.
1. Anti-inflammatory symptom reliever therapy (for mild asthma patients): Adolescents aged 12 and older and adults: Inhale as needed for symptom relief and may also be used for prevention of bronchoconstriction induced by allergens or exercise. If symptoms persist for several minutes, additional inhalation may be necessary, ensuring to not exceed 6 inhales at once. The total daily inhalation dose should not exceed 8 times, but in exceptional situations, a maximum of 12 times a day may be temporarily allowed.
1. Anti-inflammatory symptom reliever therapy: Children aged 4 and above: The efficacy and safety for patients aged 4-11 have not been studied and are therefore not recommended. 2. Maintenance therapy including anti-inflammatory symptom relief: Children under 12 years
This medication contains two components, Budesonide and Formoterol, which are inhaled. This medication should not be used by individuals allergic to Budesonide, Formoterol, or lactose used in inhaled products, or in children under 6 years of age. Patients who have previously received systemic steroid treatment and are suspected to have adrenal insufficiency should use this medication with extra caution. Using this medication may result in symptoms such as tremors or palpitations, which are common side effects of the components and are generally mild, resolving within a few days. Patients with chronic obstructive pulmonary disease need to be cautious as there may be a risk of skin bruising or pneumonia. This medication may cause various side effects including palpitations, tachycardia, nausea, headache, cough, hoarseness, oral candidiasis (fungal infection in the mouth), etc. Particularly when high doses are used over the long term, systemic side effects such as adrenal insufficiency, growth retardation, decreased bone density, cataracts, and glaucoma can occur. This medication should not be suddenly discontinued but rather should be gradually reduced in dosage according to a doctor’s instructions. If asthma or pulmonary disease symptoms worsen, immediate consultation with medical personnel is required. This medication may also be effective in preventing bronchospasm caused by exercise or allergic reactions, so it should be used as appropriate for symptoms. When using this medication, it is important to consistently inhale as prescribed by a doctor, and continue maintenance therapy even if symptoms are absent. This medication can interact with other drugs, so it is essential to inform medical personnel, especially when used with beta-blockers or specific antifungal agents. If pregnant or breastfeeding, this medication should only be used cautiously at the minimum effective dose when necessary, and after consulting with a doctor. In children, growth status should be regularly monitored, and if growth retardation is suspected, the treatment method should be re-evaluated. In the case of overdose, symptoms such as tremors, headache, palpitations, hyperglycemia, hypokalemia, etc., may occur, so if any abnormal symptoms arise, immediate consultation with medical personnel is required. When using this medication, rinse the mouth with water after inhalation to reduce the risk of oral candidiasis, and keep the inhaler clean. During inhalation, it is important to inhale deeply and avoid exhaling into the inhaler, and to close the inhaler properly after use. This medication does not affect driving or machinery operation capability; however, symptoms can vary by individual, so caution is necessary. Patients with chronic obstructive pulmonary disease should be alert to changes in symptoms due to increased risk of pneumonia.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to avoid exposure to air or moisture, preferably at a cool temperature below 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer period.
A specially designed inhaler made of plastic filled with spherical granules
60 doses/canister, 120 doses/canister
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Budesonide Micronized 180mg · Formoterol Fumarate Hydrate 5mg
Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
Budesonide Micronized 90mg · Formoterol Fumarate Hydrate 5mg
Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
Budesonide Micronized 390mg · Formoterol Fumarate Hydrate 11mg
Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.